Insulin Pump Market Size To Reach $13.1 Billion By 2033

June 2026 | Report Format: Electronic (PDF)

Insulin Pump Market Growth & Trends

The global insulin pump market size is estimated to reach USD 13.1 billion by 2033, registering to grow at a CAGR of 7.8% from 2026 to 2033, according to a new report by Grand View Research, Inc. The key factors driving the growth of the market are the technological advancements and the adoption of pumps over traditional methods. These pumps are very convenient for people who require daily multiple injections of insulin.

Insulin pump is a machine that enables insulin to be delivered either manually or automatically. These pumps can be programmed to deliver a specific set of doses and can also deliver a larger set of doses of glucose whenever required, such as before a meal. Patients can connect these devices to their smartphones to calibrate blood glucose readings. Technological advancement and new product launches across the globe are also fueling the market during the forecast period. For instance, Medtronic’s MiniMed 670G system is the world’s first hybrid closed loop system that acts as an artificial pancreas. The system provides automated insulin delivery as per the patient’s CGM readings.

The insulin pumps market is anticipated to witness a high growth rate during the forecast period due to the continuous efforts for diabetes control by government and healthcare organizations such as the International Diabetes Federation (IDF). These organizations provide required expertise and support diabetes awareness campaigns through a network of stakeholders and partners. Also, increasing health care funding is anticipated to propel growth. Additionally, the market is expected to witness a shift from the usage of traditional tethered pumps to patch pumps driven by their compact size and ease of use.

key Request a free sample copy or view report summary: Insulin Pump Market Report

Insulin Pump Market Report Highlights

The tubed pump segment held the largest market share of 59.4% in 2025, supported by its widespread clinical adoption, substantial installed base, and demonstrated effectiveness in providing accurate insulin therapy.
The open-loop systems segment led the market in 2025, accounting for a 52.6% share, driven by its extensive installed base, widespread availability across global markets, and lower cost relative to fully automated closed-loop systems.
Homecare emerged as the leading segment in the insulin pump industry, accounting for an 84.4% share in 2025. This dominance is primarily attributed to the growing adoption and widespread use of insulin pumps in home-based diabetes management.
The North America insulin pumps market accounted for the largest share of 45.4% in 2025, driven by the rising prevalence of diabetes across the region, which continues to support the adoption of insulin pump technologies.